| About Entrez
Help | FAQ
Single Citation Matcher
Batch Citation Matcher
reuptake inhibitors fluoxetine and fluvoxamine induce hyperglycemia by
Yamada J, Sugimoto Y, Inoue
Department of Pharmacology, Kobe Pharmaceutical
University, Motoyamakita-machi, Higashinada-ku, Kobe, Japan.
The effects of the selective
serotonin reuptake inhibitors, fluoxetine and fluvoxamine, on plasma
glucose levels were investigated in mice. Both fluoxetine and
fluvoxamine elicited significant hyperglycemia, while a selective
noradrenaline reuptake inhibitor maprotiline had no effect. Fluoxetine
and fluvoxamine did not change serum insulin levels, although they
elicited hyperglycemia. Pretreatment with the serotonin
(5-hydroxytryptamine, 5-HT) depleter, p-chlorophenylalanine (pCPA),
abolished fluvoxamine-induced hyperglycemia, although pCPA did not
affect the fluoxetine-induced glycemic effects. These results suggest
that the selective serotonin reuptake inhibitors fluoxetine and
fluvoxamine induce hyperglycemia by inhibition of insulin release.
Moreover, our findings indicate that the glycemic effects of these drugs
are differentially associated with serotonergic mechanisms.
10556672 [PubMed - indexed for MEDLINE]